IP Verse

Treatment Of Cancer By Manipulation Of Commensal Microflora - EP3303401

The patent EP3303401 was granted to The University OF Chicago on Oct 16, 2024. The application was originally filed on Jun 1, 2016 under application number EP16804316A. The patent is currently recorded with a legal status of "Granted And Under Opposition".

EP3303401

THE UNIVERSITY OF CHICAGO
Application Number
EP16804316A
Filing Date
Jun 1, 2016
Status
Granted And Under Opposition
Sep 13, 2024
Grant Date
Oct 16, 2024
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

HGFJul 16, 2025HGFADMISSIBLE

Patent Citations (18) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication NumberPublication Link
DESCRIPTIONEP2876167
DESCRIPTIONUS4816567
DESCRIPTIONUS4946778
DESCRIPTIONUS5260203
DESCRIPTIONUS8449878
DESCRIPTIONWO2005032567
DESCRIPTIONWO8801649
EXAMINATIONUS2019224253
EXAMINATIONWO2005032567
INTERNATIONAL-SEARCH-REPORTEP2876167
INTERNATIONAL-SEARCH-REPORTUS7195906
INTERNATIONAL-SEARCH-REPORTWO2011068810
INTERNATIONAL-SEARCH-REPORTWO2014145958
INTERNATIONAL-SEARCH-REPORTWO2015061372
OPPOSITIONEP2876167
OPPOSITIONUS2009217401
OPPOSITIONWO2016063263
SEARCHEP2876167

Non-Patent Literature (NPL) Citations (68) New

NPL citations refer to non-patent references such as research papers, articles, or other publications cited during examination or opposition phases.

Citation PhaseReference TextLink
DESCRIPTION- BAK et al., Journal of immunology, (20120000), vol. 189, pages 1708 - 1716-
DESCRIPTION- BLANK et al., Cancer research, (20040000), vol. 64, pages 1140 - 1145-
DESCRIPTION- CAPORASO et al., Bioinformatics, (20100000), vol. 26, pages 266 - 267-
DESCRIPTION- CAPORASO et al., Nat Meth, (20100000), vol. 7, pages 335 - 336-
DESCRIPTION- CHOTHIA, C. et al., Nature, (19890000), vol. 342, pages 878 - 883-
DESCRIPTION- CHOTHIA, C.LESK, A. M., J. Mol. Biol., (19870000), vol. 196, pages 901 - 917-
DESCRIPTION- CLACKSON et al., Nature, (19910000), vol. 352, pages 624 - 628-
DESCRIPTION- COMPEER et al., Frontiers in Immunology, (20120000), vol. 3-
DESCRIPTION- DONG et al., Early human development, (20100000), vol. 86, pages 51 - 58-
DESCRIPTION- FUERTES et al., The Journal of experimental medicine, (20110000), vol. 208, pages 2005 - 2016-
DESCRIPTION- GAJEWSKI et al., Cancer j ournal, (20100000), vol. 16, pages 399 - 403-
DESCRIPTION- GAJEWSKI et al., Cancer journal, (20100000), vol. 16, pages 399 - 403-
DESCRIPTION- GANAL et al., Immunity, (20120000), vol. 37, pages 158 - 170-
DESCRIPTION- GOTO et al., Immunity, (20140000), vol. 40, pages 594 - 607-
DESCRIPTION- HAMID et al., The New England journal of medicine, (20130000), vol. 369, pages 134 - 144-
DESCRIPTION- HODI, F. S. et al., The New England journal of medicine, (20100000), vol. 363, pages 711 - 723-
DESCRIPTION- HUDSON et al., Nat. Med., (20030000), vol. 9, pages 129 - 134-
DESCRIPTION- IVANOV et al., Cell, (20090000), vol. 139, pages 485 - 498-
DESCRIPTION- JANCIC et al., Nature cell biology, (20070000), vol. 9, pages 367 - 378-
DESCRIPTION- JI et al., Cancer immunology, immunotherapy : CII, (20120000), vol. 61, pages 1019 - 1031-
DESCRIPTION- KABASHIMA et al., The American Journal of Pathology, (20070000), vol. 171, pages 1249 - 1257-
DESCRIPTION- KOHLERMILSTEIN, Nature, (19750000), vol. 256, pages 495 - 499-
DESCRIPTION- LOPEZ et al., International journal of food microbiology, (20100000), vol. 138, pages 157 - 165-
DESCRIPTION- LOZUPONE et al., Appl Environ Microbiol, (20050000), vol. 71, pages 8228 - 8235-
DESCRIPTION- MACKEY et al., Journal of immunology, (19500000), vol. 161, pages 2094 - 2098-
DESCRIPTION- MACKEY et al., Journal of immunology, (19980000), vol. 161, pages 2094 - 2098-
DESCRIPTION- MARKS et al., J. Mol. Biol., (19910000), vol. 222, pages 581 - 597-
DESCRIPTION- MAZMANIAN et al., Cell, (20050000), vol. 122, pages 107 - 118-
DESCRIPTION- MCDONALD et al., The ISME journal, (20120000), vol. 6, pages 610 - 618-
DESCRIPTION- MENARD et al., Applied and Environmental Microbiology, (20080000), vol. 74, pages 660 - 666-
DESCRIPTION- NUKIWA et al., European journal of immunology, (20060000), vol. 36, pages 1019 - 1027-
DESCRIPTION- PAN et al., Immunology letters, (20040000), vol. 94, pages 141 - 151-
DESCRIPTION- PETTIT et al., Journal of immunology, (19970000), vol. 159, pages 3681 - 3691-
DESCRIPTION- ROUND et al., Proceedings of the National Academy of Sciences of the United States of America, (20100000), vol. 107, pages 12204 - 12209-
DESCRIPTION- SCHOLER et al., Immunity, (20080000), vol. 28, pages 258 - 270-
DESCRIPTION- SPRANGER et al., Science translational medicine, (20130000), vol. 5, page 200ra1 16-
DESCRIPTION- STOBER et al., Infection and Immunity, (20070000), vol. 75, pages 5059 - 5067-
DESCRIPTION- TOPALIAN, S. L. et al., Journal of clinical oncology, (20140000), vol. 32, pages 1020 - 1030-
DESCRIPTION- TOPALIAN, S. L. et al., The New England journal of medicine, (20120000), vol. 366, pages 2443 - 2454-
DESCRIPTION- TUMEH et al., Nature, (20140000), vol. 515, pages 568 - 571-
DESCRIPTION- VIAUD et al., Science, (20130000), vol. 342, pages 971 - 976-
DESCRIPTION- WANG et al., Appl Environ Microbiol, (20070000), vol. 73, pages 5261 - 5267-
DESCRIPTION- WOLCHOK, J. D. et al., The New England Journal of Medicine, (20130000), vol. 369, pages 122 - 133-
DESCRIPTION- WOO et al., Immunity, (20100000), vol. 32, pages 815 - 827-
DESCRIPTION- ZHANG et al., New England Journal of Medicine, (20030000), vol. 348, pages 203 - 213-
EXAMINATION- Anonymous, "Research reveals DuPont Probiotic leads to reduction in weight gain, improved glucose tolerance", (20150305), URL: https://www.foodprocessing-technology.com/news/newsresearch-reveals-dupont-probiotic-leads-reduction-weight-gain-improved-glucose-tolerance-4526417/, (20220609), XP055929687-
INTERNATIONAL-SEARCH-REPORT- ZITVOGEL, L et al., "Cancer and the gut microbiota: An unexpected link.", Science Translation Medicine., (20150121), vol. 7, no. 271, XP055333413 [Y] 10-12 * ; page 3, column 2, paragraph 2, lines 7-9 *
OPPOSITION- D13 - Reply Declaration of Jonathan Braun. Filed in support of Post Grant review of US Patent No. 9,855,302-
OPPOSITION- D14 - Calculations in relation to OTU described in the patent-
OPPOSITION- D6 - Declaration of Jonathan Braun. Filed in support of Post Grant review of US Patent No. 9,855,302-
OPPOSITION- Dheeraj Mohania, Vinod K Kansal, Manoj Kumar, Ravinder Nagpal, Yuichiro Yamashiro, Francesco Marotta, "Modulation of expression of Programmed Death-1 by administration of probiotic Dahi in DMH-induced colorectal carcinogenesis in rats", ATENEO PARMENSE. ACTA BIOMEDICA, MATTIOLI 1885 SPA, FIDENZA, IT, IT , (20130901), vol. 84, no. 2, ISSN 0392-4203, pages 102 - 109, XP009562274-
OPPOSITION- Y. Kohwi, K. Imai, Z. Tamura, "Antitumor Effect Of Bifidobacterium Infantis In Mice", Gann, (19781001), vol. 69, pages 613 - 618, XP009562270-
OPPOSITION- Lopez et al., "Distinct Bifidobacterium strains drive different immune responses in vitro", International Journal of Food Microbiology, (2010), vol. 138, doi:10.1016/j.ijfoodmicro.2009.12.023, pages 157 - 165, XP026920572
OPPOSITION- Grimoud et al, "In vitro screeding of probiotics and synbiotics according to anti-inflammatory and anti-proliferative effects", International Journal of Food Microbiology, (2010), vol. 144, doi:10.1016/j.ijfoodmicro.2010.09.007, pages 42 - 50, XP027481261
OPPOSITION- Ohaegbulam et al, "Human cancer immunotherapy with antibodies to the PD-1 and PD-L1 pathway", Trends Mol. Med., (201501), vol. 21, doi:10.1016/j.molmed.2014.10.009, XP055249717
OPPOSITION- Twyman-Saint Victor et al, "Radiation and Dual Checkpoint Blockade Activates Non-Redundant Immune Mechanisms in Cancer", Nature, (201504), vol. 520, doi:10.1038/nature14292, pages 373 - 377, XP055606336
OPPOSITION- P.A. Lynch , B.J. Gilpin , L.W. Sinton , M.G. Savill, "The detection of Bifidobacterium adolescentis by colony hybridization as an indicator of human faecal pollution", Journal of Applied Microbiology, Oxford University Press, Oxford UK, Oxford UK, (20020301), vol. 92, no. 3, doi:10.1046/j.1365-2672.2002.01557.x, ISSN 1364-5072, pages 526 - 533, XP009562276
OPPOSITION- Ventura Marco, Canchaya Carlos, Casale Antonio Del, Dellaglio Franco, Neviani Erasmo, Fitzgerald Gerald F., Van Sinderen Douwe, "Analysis of bifidobacterial evolution using a multilocus approach", INTERNATIONAL JOURNAL OF SYSTEMATIC AND EVOLUTIONARY MICROBIOLOGY, Society for General Microbiology, GB, GB , (20061201), vol. 56, no. 12, doi:10.1099/ijs.0.64233-0, ISSN 1466-5026, pages 2783 - 2792, XP093301017
OPPOSITION- Lee Do Kyung; Jang Seok; Kim Mi Jin; Kim Jung Hyun; Chung Myung Jun; Kim Kyung Jae; Ha Nam Joo, "Anti-proliferative effects of Bifidobacterium adolescentis SPM0212 extract on human colon cancer cell lines", BMC Cancer, BIOMED CENTRAL, LONDON, GB, LONDON, GB , (20081027), vol. 8, no. 1, doi:10.1186/1471-2407-8-310, ISSN 1471-2407, page 310, XP021042948
OPPOSITION- Bian Jessica, Almhanna Khaldoun, "Pancreatic cancer and immune checkpoint inhibitors—still a long way to go", Translational Gastroenterology and Hepatology, vol. 6, doi:10.21037/tgh.2020.04.03, ISSN 2415-1289, pages 6 - 6, XP093301020
SEARCH- Mark Zipkin ET AL, "Microbiome at the checkpoint", BC Innovations, Cover Story, United States, (20151203), URL: https://evelobio.com/wp-content/uploads/2018/03/CTLA-4andPD-L1blockadedependsonspecificcommensalbacteria-BioCentury.com1_.pdf, (20181112), XP055522712 [T] 1-13 * the whole document *-
SEARCH- PING DONG ET AL, "The role of intestinal bifidobacteria on immune system development in young rats", EARLY HUMAN DEVELOPMENT, IR, (20100101), vol. 86, no. 1, doi:10.1016/j.earlhumdev.2010.01.002, ISSN 0378-3782, pages 51 - 58, XP055522699 [YD] 1-13 * the whole document * * abstract *
SEARCH- LOPEZ P ET AL, "Distinct Bifidobacterium strains drive different immune responses in vitro", INTERNATIONAL JOURNAL OF FOOD MICROBIOLOGY, ELSEVIER BV, NL, vol. 138, no. 1-2, doi:10.1016/J.IJFOODMICRO.2009.12.023, ISSN 0168-1605, (20100331), pages 157 - 165, (20100104), XP026920572 [YD] 1-13 * the whole document * * abstract *
SEARCH- S VIAUD ET AL, "Gut microbiome and anticancer immune response: really hot Sh*t!", CELL DEATH AND DIFFERENTIATION., GB, (20140516), vol. 22, no. 2, doi:10.1038/cdd.2014.56, ISSN 1350-9047, pages 199 - 214, XP055227164 [A] 1-13 * the whole document *
SEARCH- A. SIVAN ET AL, "Commensal Bifidobacterium promotes antitumor immunity and facilitates anti-PD-L1 efficacy", SCIENCE, (20151127), vol. 350, no. 6264, doi:10.1126/science.aac4255, ISSN 0036-8075, pages 1084 - 1089, XP055310361 [T] 1-13 * the whole document *
SEARCH- MENARD O ET AL, "Gnotobiotic mouse immune response induced by Bifidobacterium sp. strains isolated from infants", APPLIED AND ENVIRONMENTAL MICROBIOLOGY, AMERICAN SOCIETY FOR MICROBIOLOGY, US, vol. 74, no. 3, doi:10.1128/AEM.01261-07, ISSN 0099-2240, (20080201), pages 660 - 666, (20071214), XP002573761 [YD] 1-13 * the whole document * * abstract *
SEARCH- DOMENICA REA ET AL, "Microbiota effects on cancer: from risks to therapies", ONCOTARGET, (20180402), vol. 9, no. 25, doi:10.18632/oncotarget.24681, pages 17915 - 17927, XP055522164 [T] 1-13 * the whole document *
SEARCH- SOPHIE VIAUD ET AL, "Why should we need the gut microbiota to respond to cancer therapies?", ONCOIMMUNOLOGY, (20140101), vol. 3, no. 1, doi:10.4161/onci.27574, page e27574, XP055169892 [Y] 1-13 * the whole document *

Download Citation Report

Get a free citation report including examiner, opposition, and international search citations.

Get Citation Report

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents